Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antithymocyte Globulin”

204 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 204 results

Very early researchEnded earlyNCT01318915
What this trial is testing

Research Study of ATG and Rituximab in Renal Transplantation

Who this might be right for
Renal Transplant Recipients
National Institute of Allergy and Infectious Diseases (NIAID) 10
Testing effectiveness (Phase 2)Looking for participantsNCT07269041
What this trial is testing

Immune Tolerance Induction After Liver Transplantation

Who this might be right for
Liver TransplantationImmune ToleranceImmune Tolerance/Drug Effects+6 more
University of California, Los Angeles 12
Testing effectiveness (Phase 2)Active Not RecruitingNCT00319657
What this trial is testing

Kidney and Blood Stem Cell Transplantation That Eliminates Requirement for Immunosuppressive Drugs

Who this might be right for
Immune Tolerance
Stanford University 15
Large-scale testing (Phase 3)Study completedNCT04302805
What this trial is testing

RATG Versus rATG Combined With Intravenous Immunoglobulin (IVIG) Induction Immunosuppression in HLA Incompatible Transplantation (INHIBIT)

Who this might be right for
Kidney Transplantation
Institute for Clinical and Experimental Medicine 17
Testing effectiveness (Phase 2)Ended earlyNCT00635024
What this trial is testing

Anti-thymocyte Globulin and Melphalan in Treating Patients With Relapsed Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Mayo Clinic 1
Early research (Phase 1)Looking for participantsNCT05525507
What this trial is testing

Delayed Immunological Tolerance in Patients With Well-functioning Pre-existing HLA-matched Kidney Transplants

Who this might be right for
End Stage Kidney DiseaseImmunological ToleranceKidney Transplant Failure and Rejection+1 more
University of California, Los Angeles 10
Testing effectiveness (Phase 2)Study completedNCT02215200
What this trial is testing

ATG-GCSF in New Onset Type 1 Diabetes

Who this might be right for
Diabetes Mellitus, Type 1
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 89
Large-scale testing (Phase 3)Study completedNCT00004208
What this trial is testing

Antithymocyte Globulin and Cyclosporine in Treating Patients With Myelodysplastic Syndrome

Who this might be right for
Myelodysplastic Syndromes
Swiss Cancer Institute 86
Post-approval studies (Phase 4)Study completedNCT01883180
What this trial is testing

ATG in Haploidentical HSCT for Acute Graft-versus-host Disease Prophylaxis

Who this might be right for
Hematopoietic Stem Cell TransplantationAntithymocyte GlobulinViral Infection
Nanfang Hospital, Southern Medical University 412
Not applicableStudy completedNCT00859131
What this trial is testing

Safety and Efficacy Study of Thymoglobulin Versus IL2 Receptor Antagonists

Who this might be right for
End Stage Renal Disease
Medical University of South Carolina 200
Large-scale testing (Phase 3)Study completedNCT05166967
What this trial is testing

Targeted Dose Study of ATG in Haploidentical Hematopoietic Stem Cell Transplantation

Who this might be right for
Haploidentical Hematopoietic Stem Cell Transplantation
Chinese PLA General Hospital 204
Testing effectiveness (Phase 2)Study completedNCT00076570
What this trial is testing

Combination Drug Therapy Followed by Single Drug Steroid Free Therapy to Prevent Organ Rejection in Kidney Transplantation

Who this might be right for
Kidney Transplantation
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 31
Post-approval studies (Phase 4)Study completedNCT00113269
What this trial is testing

Safety/Efficacy of Induction Agents With Tacrolimus, MMF, and Rapid Steroid Withdrawal in Renal Transplant Recipients

Who this might be right for
Kidney Transplantation
Astellas Pharma Inc 501
Testing effectiveness (Phase 2)Ended earlyNCT01375023
What this trial is testing

Allogenic Haematopoietic Cell Transplantation for Patients With Refractory "Triple Negative" Breast Cancer

Who this might be right for
Breast Cancer
European Institute of Oncology 3
Testing effectiveness (Phase 2)WithdrawnNCT02586831
What this trial is testing

Diabetes Islet Preservation Immune Treatment

Who this might be right for
Diabetes Mellitus, Type 1HypoglycemiaAutoimmune Diseases+1 more
Camillo Ricordi and Jay Skyler
Testing effectiveness (Phase 2)Study completedNCT00886522
What this trial is testing

Intrabone Infusion of Cord Blood in Adults With Hematological Malignancies

Who this might be right for
Hematological Malignancies
IRCCS Azienda Ospedaliero-Universitaria di Bologna 23
Not applicableEnded earlyNCT00235781
What this trial is testing

Single Dose Thymoglobulin for Induction in Adult Renal Allograft Recipients

Who this might be right for
Kidney Transplantation
Washington University School of Medicine 90
Testing effectiveness (Phase 2)Ended earlyNCT00617929
What this trial is testing

Antithymocyte Globulin, Clofarabine, and Rituximab in Treating Patients After an Unsuccessful Stem Cell Transplant

Who this might be right for
Cancer
Masonic Cancer Center, University of Minnesota 12
Not applicableUnknownNCT06039436
What this trial is testing

Conditioning Regimen Containing Low Dose ATG for The Treatment of Acquired SAA Receiving sUCBT

Who this might be right for
Severe Aplastic Anemia
Anhui Provincial Hospital 72
Early research (Phase 1)Study completedNCT00010335
What this trial is testing

Pilot Study of Total Body Irradiation in Combination With Cyclophosphamide, Anti-thymocyte Globulin, and Autologous CD34-Selected Peripheral Blood Stem Cell Transplantation in Children With Refractory Autoimmune Disorders

Who this might be right for
Systemic SclerosisSystemic Lupus ErythematosusDermatomyositis+2 more
Fred Hutchinson Cancer Center 6
Load More Results